DOPAMINE AGONISTS AND HRT
Population pharmacokinetic analysis of clinical study data showed that oestrogens
(from HRT) reduced ropinirole clearance by one-third.
In women already receiving HRT, ropinirole treatment may be started using the
usual dose titration. However, a reduction in the ropinirole dosage may be needed
if HRT is started, and an increase if it is withdrawn.
(from HRT) reduced ropinirole clearance by one-third.
In women already receiving HRT, ropinirole treatment may be started using the
usual dose titration. However, a reduction in the ropinirole dosage may be needed
if HRT is started, and an increase if it is withdrawn.